‹ All Posts
Palak Jain

23rd Jul 2025 · SEBI-Registered Analyst

📢
NATCOPHARM
Pharma | Major Strategic Moves Announced

✅ To Acquire 35.75% Stake in Adcock Ingram Holdings, South Africa  🔹 Investment: ₹2,000 Cr @ ZAR 75/share ✅ To Set Up Wholly-Owned Subsidiary in South Africa  🔹 Investment Cap: ₹2,100 Cr ✅ To Liquidate Time Cap Overseas Ltd and directly hold stake in Brazilian unit 🌐 Strengthening global footprint in South Africa & Brazil

#TechnicalViews#FundamentalViews#MacroViews#EquityResearch#TrendingSectors
1,086 likes·62 comments